603858.SHG Shandong Buchang Pharmaceuticals Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
15.12 CNY
Close of Nov 4, 2026
14.01 18.47
Market cap
CNY 15.9B
P/E
54.0x
P/B
1.58x
ROE
10.2%
Dividend yield
3.33%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603858.SHG undervalued?

Graham number
Price15.12
Graham value7.78
Premium94.5%

603858.SHG trades 94.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shandong Buchang Pharmaceuticals Co Ltd fundamental analysis

No fundamental analysis for Shandong Buchang Pharmaceuticals Co Ltd yet.

Shandong Buchang Pharmaceuticals Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shandong Buchang Pharmaceuticals Co Ltd

Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicines in China and internationally. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China.

Full company profile